סרטן הערמונית בסיכון גבוה
סרטן הערמונית בסיכון גבוה.
מרצים
ד”רתומר חרס
רופא בכיר, מנהל תחום אונקואורלוגיה, יחידת קרינה, המערך האונקולוגי.
מאמרים רלבנטיים
קישור למאמרים המוזכרים בהרצאה.
- Chen N, Zhou Q. The evolving Gleason grading system. Chin J Cancer Res 2016;28.
- Epstein Zelefsky et al. Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score European urology 2015.
- Spratt Zelefsky et al. Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer. IJROBP 2012.
- Veeru Kasivisvanathan et.al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis, N Engl J Med 2018; 378:1767-1777.
- Nguyen, P., Martin, N., Choeurng, V. et al. Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer. Prostate Cancer Prostatic Dis 20, 186–192 (2017).
- Kupelian et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer IJROBP 2004; Vol 58.
- International Journal of Radiation Oncology*Biology*Physics, Volume 98, Issue 2, 1 June 2017, Pages 275-285.
- Kishan, A. U King, C. R. (2018). Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. JAMA, 319(9), 896. doi:10.1001/jama.2018.0587.
- Nicholas DJ et al. Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy N Engl J Med 2017; 377:338-351.
